The anti mullerian hormone- a novel marker for assessing the ovarian reserve in women with regular menstrual cycles.

BACKGROUND Ovarian Reserve (OR) is a term which describes the functional potential of the ovary, which constitutes the size of the ovarian follicle pool and reflects the number and quality of the oocytes which are within it. Assessment of the OR helps in reflecting the reproductive potential of women. Various markers are available for assessing the OR and the best marker is the Anti Mullerian Hormone (AMH) which reflects the ovarian follicular pool in the ovary. In this study, the serum level of AMH/MIS(Mullerian Inhibiting Substance)was estimated to assess the ovarian reserve in both fertile and infertile women. OBJECTIVE To assess the ovarian reserve in women of the fertile and subfertile groups with regular cycles, who were in the age range of 26 -33yrs, by estimating the level of AMH and those of other hormones like FSH and E2 and also to calculate the ovarian volume and the Antral follicular count by an ultrasonographic method. MATERIALS AND METHODS Thirty fertile and thirty sub fertile women whose ages ranged from 26-33yrs were included as group 1 and group 2 respectively. The hormones like AMH ,FSH and oestradiol were assayed. Measurement of the ovarian volume and the antral follicular count by doing a transvaginal ultrasonogram, was done in all the subjects who were involved in both the groups. The correlation test was studied between the variables and the test of significance of the variables between the 2 groups was also analyzed by the Statistical Package Of Social Sciences (SPSS). RESULTS The Antral Follicular Count (AFC) and the ovarian volume were negatively correlated with the age. The ovarian volume was positively correlated with the AFC. The FSH negatively correlated with the AFC. The Anti Mullerian Hormone negatively correlated with the age, and it positively correlated with the AFC. The mean values of AFC, FSH, and AMH were also statistically significant between the two groups. CONCLUSION AMH can be considered as a marker for assessing the ovarian reserve, as it is cycle independent as compared to the other hormones. The women in the subfertile group with low levels of AMH should be insisted to proceed for ART as early as possible.

[1]  M. Heineman,et al.  Ovarian reserve testing and the use of prognostic models in patients with subfertility. , 2001, Human reproduction update.

[2]  R. Kryscio,et al.  Ovarian volume related to age. , 2000, Gynecologic oncology.

[3]  K. Biberoğlu,et al.  Age-related changes in ovarian volume ,antral follicle counts and basal follicle stimulating hormone levels: comparison between fertile and infertile women , 2003, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[4]  Urvashi B Singh,et al.  Anti-Mullerian Hormone: A New Marker of Ovarian Function , 2014, The Journal of Obstetrics and Gynecology of India.

[5]  R. Scott,et al.  Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. , 2000, Fertility and sterility.

[6]  M. Eijkemans,et al.  Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. , 2004, Human reproduction.

[7]  Y. Siow,et al.  Serum müllerian-inhibiting substance levels during normal menstrual cycles. , 2000, Fertility and sterility.

[8]  D. H. Mendez Lozano,et al.  Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status. , 2006, Reproductive biomedicine online.

[9]  M. Perloe,et al.  Strategies for ascertaining ovarian reserve among women suspected of subfertility. , 2000, International journal of fertility and women's medicine.

[10]  P. Pearson,et al.  The variability of female reproductive ageing. , 2002, Human reproduction update.

[11]  H. Martikainen,et al.  Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. , 1997, Human reproduction.

[12]  S. Nelson,et al.  Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. , 2008, Human reproduction.

[13]  F. Broekmans,et al.  Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. , 2002, Human reproduction.

[14]  A. Volpe,et al.  Anti‐Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? , 2006, Clinical endocrinology.